A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation
Hodgkin`s lymphoma (HL) is highly curable disease in its early stages, but in advanced stages, it presents a dilemma when it becomes refractory or relapses after several rounds of chemotherapy. Brentuximab vedotin (BV) is an antibody-drug conjugate that targets the tumor necrosis receptor family pr...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hacettepe University Institute of Child Health
2019-10-01
|
| Serier: | The Turkish Journal of Pediatrics |
| Fag: | |
| Online adgang: | https://turkjpediatr.org/article/view/754 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|